Article Details

Article Type

Case Report

DOI

10.7573/dic.212569

Publication Dates

Accepted: ; Published: .

Citation

Accurso V, Santoro M, Mancuso S, Napolitano M, Di Piazza F, Russo A, Siragusa SM. Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system. Drugs in Context 2019; 8: 212569. DOI: 10.7573/dic.212569

Article Views

Monthly article views (last 2 months)

Drugs in Context PubMed Central
Source HTML views PDF downloads Totals
Drugs in Context since November 11, 2025 78 20 98
PubMed Central since October 1, 2025 1 0 1
Totals 79 20 79
Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.